ProCE Banner Activity

Experts Address HCP Questions on Contemporary Treatment for CLL

Clinical Thought

In this commentary, expert faculty address questions from a live audience at ASH 2022 on current and emerging management strategies for patients with chronic lymphocytic leukemia.

Released: January 30, 2023

Expiration: January 29, 2024

Share

Faculty

Deborah M Stephens

Deborah M Stephens, DO

Associate Professor
Director of the CLL and Richters Program
Lineberger Comprehensive Cancer Center
University of North Carolina at Chapel Hil
Chapel Hill, North Carolina

Jennifer A. Woyach

Jennifer A. Woyach, MD

D. Warren Brown Professor of Leukemia Research
Division of Hematology
The Ohio State University
Columbus, Ohio

Provided by

Provided by National Comprehensive Cancer Network, in partnership with Clinical Care Options, LLC

ProCE Banner

Supporters

AstraZeneca

BeiGene

Lilly

Pharmacyclics LLC an AbbVie Company and Janssen Biotech Inc